Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
53.47
+2.19 (4.27%)
At close: Mar 10, 2026
Shanghai Rendu Biotechnology Employees
Shanghai Rendu Biotechnology had 290 employees as of June 30, 2025. The number of employees decreased by 45 or -13.43% since the number was reported on December 31, 2024.
Employees
290
Change
-45
Growth
-13.43%
Revenue / Employee
483.77K CNY
Profits / Employee
28.39K CNY
Market Cap
1.99B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 290 | -45 | -13.43% |
| Dec 31, 2024 | 335 | -23 | -6.42% |
| Dec 31, 2023 | 358 | -171 | -32.33% |
| Dec 31, 2022 | 529 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Chemclin Diagnostics | 606 |
| Medicalsystem Biotechnology | 2,104 |
| Guangdong Hybribio Biotech | 2,205 |
| Berry Genomics Co.,Ltd | 1,402 |
| Shanghai Labway Clinical Laboratory | 1,365 |
| Thalys Medical Technology Group | 1,246 |
| SMO ClinPlus CO.,LTD. | 4,271 |
| Cowealth Medical China | 203 |